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Muscle diseases with damaged sarcomeres - causes and consequences
Monica Ohlsson, Department of Clinical Neuroscience and Rehabilitation, The Sahlgrenska 
Academy at University of Gothenburg, SU/Sahlgrenska, SE-413 45 Gothenburg, Sweden
Muscle diseases, also called myopathies, are usually defined as diseases where the pathology is 
confined to  the  muscle  itself.  This  excludes  diseases  caused  by structural  abnormalities  in  the 
peripheral nerve, from the anterior horn cell to the neuromuscular junction. Much effort has been 
made  to  elucidate  the  pathogenesis  of  skeletal  muscle  diseases  that  result  from  mutations  in 
sarcomeric and associated proteins, highlighting their importance in normal muscle structure and 
function. The short-term goals in this field are to determine the remaining causative genes behind 
the skeletal muscle diseases and to learn more about the pathogenesis behind these diseases. The 
long-term goals are to develop more specific therapy in the future. 
In paper I we investigated two children with nemaline myopathy and identified  two  de novo 
heterozygous mutations not previously described in the skeletal α-actin gene (ACTA1). The marked 
variability  in  clinical  features  in  spite  of  similar  muscle  pathology  in  early  childhood  was 
demonstrated. The severe muscle atrophy with replacement of fat and connective tissue found in 
one of the patients demonstrated that nemaline myopathy might be progressive in some cases. 
In  paper  II  we  investigated  a  mother  and  daughter  with  similar  clinical  but  different 
morphological features, nemaline myopathy and cap disease. We identified a heterozygous missense 
mutation in  the  β-tropomyosin gene,  TPM2, the  first mutation  to  be found in cap disease.  We 
concluded that candidate genes in cap disease ought to be found within the genes encoding for 
sarcomeric  proteins,  especially  those  previously  associated  with  nemaline  myopathy  and  that 
mutations in TPM2 might be a common cause of cap disease.
In paper III we investigated three unrelated patients and identified three  de novo heterozygous 
mutations in TPM2: a three–base pair deletion in-frame, a three-base pair duplication in-frame, and 
a missense mutation. The hypothesis that mutations in  TPM2 are a common cause of cap disease 
was  confirmed.  In  muscle  biopsy  specimens,  a  coarse-meshed  and  irregular  intermyofibrillar 
network was found. These specific pathological findings may be clues towards a correct diagnosis 
and indicate that the pathogenesis involves defective assembly of myofilaments. 
In paper IV we had the opportunity to investigate one of the original cases of cap disease. In this 
patient we found a  de novo heterozygous missense mutation in  TPM3. The observation that cap 
disease, like nemaline myopathy, is associated with mutations in  TPM2 as well as in  TPM3 and 
shows similar clinical presentation supports our concept  that  cap disease is  related to nemaline 
myopathy and all genes encoding components of the sarcomeric thin filament should be considered 
as candidate genes in patients with cap disease.
In paper V we investigated seven individuals from two apparently unrelated families with a 
dominantly inherited adult-onset myopathy with early respiratory failure. All patients had  muscle 
weakness  in  the  pelvic  girdle,  neck  flexors  and  trunk  muscles  together  with  prominent  calf 
hypertrophy.  Muscle  histopathological  features  included  eosinophilic  deposits  and  extensive 
myofibrillar lesions with marked Z-disk alterations.  Genetic analysis with array data using SNP 
markers demonstrated that the affected individuals shared a large haplotype on chromosome 2q31, 
including the giant titin gene (TTN). Further studies include the investigation of the TTN gene and 
other genes of interest in this region.
This study has deepened the understanding of inherited myopathies associated with damaged 
sarcomeres by describing new mutations in causative genes, which in the end could lead to new 
therapy strategies.
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